Table 2 of Markoula, Mol Vis 2011; 17:1254-1260. Table 2 of Markoula, Mol Vis 2011; 17:1254-1260.
Table 2. Genotype and allele distributions of RAS polymorphisms in patients and controls
Genotypes/alleles |
Patients (47) |
Controls (76) |
|---|---|---|
| ID | 26 (55.3%) | 34 (44.7%) |
| DD | 14 (29.8%) | 30 (39.5%) |
| II | 7 (14.9%) | 12 (15.8%) |
| AC | 20 (42.6%) | 31 (40.8%) |
| AA | 25 (53.2%) | 40 (52.6%) |
| CC | 2 (4.2%) | 5 (6.6%) |
| MT | 23 (48.9%) | 40 (52.6%) |
| MM | 17 (36.2%) | 24 (31.6%) |
| TT | 7 (14.9%) | 12 (15.8%) |
| D allele presence | 40 (85.1%) | 64 (84.2%) |
| I allele presence | 33 (70.2%) | 46 (60.5%) |
| A allele presence | 45 (95.7%) | 71 (93.4%) |
| C allele presence | 22 (46.8%) | 36 (47.3%) |
| M allele presence | 40 (85.1%) | 64 (84.2%) |
| T allele presence | 30 (63.8%) | 52 (68.4%) |